Københavns Universitet
People
Claus Desler Madsen
Associate Professor
Henning Fenselau
Lead investigator
Lead investigator
Kathleen Stewart-Morgan
Lead investigator
drs. J.F. Uleman MSc
Lead investigator
Lead applicant
Postdoc Tang Cam Phung Pham
Lead investigator
Lead investigator
Pétur Heiðarsson
Lead investigator
Lead investigator
Thue W. Schwartz
Lead investigator
Lead investigator
Jens Juul Holst
Lead investigator
Lead investigator
Lead investigator
Lead investigator
Lead investigator
Rasmus Kjøbsted
Lead investigator
Lead investigator
Lead investigator
Sources: researchprofiles.ku.dk, openalex.org, grantnav.threesixtygiving.org
Trials
Changes in Intestinal Permeability and Systemic Inflammation Following Fast Food Overfeeding.
Collaborator, Recruiting, 20 people, Oct 26, 2026
Not yet recruiting, 60 people, Oct 16, 2026
Fecal Microbiota Transplantation in Females With Anorexia Nervosa
Collaborator, Not yet recruiting, 60 people, Oct 16, 2026
Hypothalamic GLP-1 Response in Healthy Weight and Obesity
Recruiting, 60 people, Oct 2, 2026
Collaborator, Phase 4, Recruiting, 1,480 people, Mar 24, 2026
GRK-Biased Activation Via β2-Adrenergic Receptors in Human Skeletal Muscle
Collaborator, Phase 2, Active, not recruiting, 13 people, Feb 19, 2026
Sustainable Diets and Cardiometabolic Health
Recruiting, 180 people, Sep 24, 2025
Effects of a High-protein Diet and Resistance Training on Fat-mass Loss Maintenance
Collaborator, Active, not recruiting, 60 people, Aug 8, 2025
Recruiting, 460 people, Jun 11, 2025
Collaborator, Phase 2, Recruiting, 108 people, Jan 20, 2025
Collaborator, Phase 3, Completed, 471 people, Dec 11, 2024
Collaborator, Phase 3, Completed, 87 people, Dec 11, 2024
Exercise Training and Type 2 Diabetes
Collaborator, Completed, 126 people, Jun 27, 2024
Resistance Training and Corticospinal Excitability in Multiple Sclerosis
Collaborator, Recruiting, 54 people, Apr 18, 2024
Protein Restriction (PR) for Weight Loss
Completed, 15 people, Feb 16, 2024
Collaborator, Phase 4, Completed, 38 people, Sep 7, 2023
Repurposing Colchicine for Reduction of Residual Inflammatory Risk in Type 1 Diabetes
Collaborator, Phase 2, Active, not recruiting, 102 people, Jul 18, 2023
Collaborator, Phase 3, Terminated, 58 people, Mar 22, 2023
MP0420 for Inpatients With COVID-19 (An ACTIV-3/TICO Treatment Trial)
Collaborator, Phase 3, Completed, 485 people, Mar 22, 2023
Collaborator, Phase 3, Completed, 1,455 people, Mar 22, 2023
Sources: clinicaltrials.gov
Grants and prizes
Hallas-Møller Ascending Investigator, Brain-body interactions conferring the aging benefits of caloric restriction, nnf-grant-b4c095fce05e2efa, DKK 24.9M, 2026, Jan 1, 2026
Metabolic Ageing, Increased complement activation at the heart of vascular dysfunction and metabolic ageing, nnf-grant-a6d8b84f22ead948, DKK 15M, 2025, Jan 1, 2025
Projektstøtte i biovidenskab og basal biomedicin, Redefining Mechanisms of Embryonic Reprogramming, nnf-grant-4d508b6b7bd467a6, DKK 4.5M, 2025, Jan 1, 2025
["Rubicon"], De cyclus doorbreken: Een systeemaanpak voor slaap, depressie en Alzheimer over de levensloop, zonmw-04520232320007-50447, 2024–2026, Jun 1, 2024
Discovery Award, The Healthy Reproductive Ageing (HERA) Study, 316959/Z/24/Z, £2.2M, 2024–2026, Jan 25, 2024
Postdoc Fellowship for Research Abroad – Bioscience and Basic Biomedicine, Exploring molecular foundations of exercise, pharmacological, and nutritional strategies to mitigate sarcopenia, nnf-grant-39af5bee39fffca7, DKK 3.9M, 2024, Jan 1, 2024
Projektstøtte i biovidenskab og basal biomedicin, Metabolic rejuvenation in stem cells - manipulating transcriptional signal-to-noise ratios to program enhanced vitality, nnf-grant-b77be5e82e46ba43, DKK 3.5M, 2024, Jan 1, 2024
Research Infrastructure, Luminosa — From single molecules to cell reprogramming, carlsberg-fondet-cf24-0822, DKK 4.7M, 2024, Jan 1, 2024
Tandem Programme, Age-related diseases: causes, mechanisms and consequences of mutated blood cells with multiple aberrations, nnf-grant-ffe4993912e1b6dd, DKK 10M, 2024, Jan 1, 2024
Pioneer Innovator, AI-ACELLERATED STRUCTURE-BASED DISCOVERY OF Y4 RECEPTOR ANTAGONISTS AS GLP-1 AND AMYLIN RECEPTOR AGONIST-ENHANCING ANTI-OBESITY DRUGS, nnf-grant-dfb1cec97e5b6797, DKK 1.1M, 2024, Jan 1, 2024
Semper Ardens: Accelerate, Adult Tissue Regeneration: Balancing Lateral inhibition and Cellular plasticity, carlsberg-fondet-cf24-1666, DKK 6.9M, 2024, Jan 1, 2024
European Foundation for the Study of Diabetes
EFSD/Lilly European Diabetes Research Programme, GLP-1 is safe from hypoglycaemia, but why?, EFSD-lilly-euro-diab-research-2023-jens-juul-holst, 2023, Jan 1, 2023
Data Science Investigators, Uncovering sex-specific epigenetic aging mechanisms for precision medicine., nnf-grant-fb3daa7a6dba6a1a, DKK 10.3M, 2023, Jan 1, 2023
Projektstøtte i klinisk og translationel lægevidenskab, CLONAL HEMATOPOIESIS IN ELDERLY TWINS: THE ROLE OF MOSAIC CHROMOSOMAL ABERRATIONS, nnf-grant-fa20b4e8c9793dd4, DKK 2M, 2021, Jan 1, 2021
AARF, Plasma Proteomics for Identification of Non-Invasive Dementia Risk Markers, AARF-21-851606, 2021, Jan 1, 2021
Research Infrastructure, Vascular calcium sensitivity and intercellular communication in aging, carlsberg-fondet-cf21-0523, DKK 261K, 2021, Jan 1, 2021
Tandem Programme, Genetic regulation of human oocyte aging (RESPOND), nnf-grant-324ab96916cd185d, DKK 10M, 2021, Jan 1, 2021
Endokrinologisk forskning - Norden, β-Cell aging and the risk of Type 2 Diabetes: does impaired membrane repolarization sensitize the β-cell to age-associated stressors?, nnf-grant-a1f187f2e14c0839, DKK 2M, 2021, Jan 1, 2021
European Foundation for the Study of Diabetes
EFSD/Lilly Young Investigator Research Award Programme, Role of skeletal muscle AMPK for the regulation of metformin action, EFSD-lilly-young-investigator-2020-rasmus-kjbsted, 2020, Jan 1, 2020
Novo Nordisk Foundation Symposia, Symposium on New Hallmarks of Aging, nnf-grant-bd99f82c82aaefff, DKK 148K, 2020, Jan 1, 2020
Sources: openalex.org, grantnav.threesixtygiving.org
Funded papers
IFSV 2012, Sep 11, 2026
Aug 7, 2026
NNF23SA0084103, NNF20SA0064340, Aug 4, 2026
Jun 29, 2026
Seismocardiography for nonexercise estimation of cardiorespiratory fitness in older adults
Jun 20, 2026
Jun 17, 2026
Jun 6, 2026
May 28, 2026
May 19, 2026
From the Discovery of GLP-1 to Today's Diabetes/Obesity Therapy and Beyond
Apr 24, 2026
Genomic analyses implicate hormonal and metabolic dysregulation in polycystic ovary syndrome
Apr 23, 2026
Apr 20, 2026
Apr 20, 2026
Apr 1, 2026
Mar 24, 2026
Exercise timing and circadian regulation of metabolism in type 2 diabetes
NNF23SA0084103, Mar 19, 2026
Mar 16, 2026
NNF23SA0084103, Mar 11, 2026
Prostate-specific antigen testing and prostate cancer-related outcomes: a Danish nationwide study
Mar 4, 2026
Feb 28, 2026
Sources: openalex.org, api.crossref.org
Named in competing interests
Grants or research support, Mar 2, 2026
Fees or honoraria, Dec 28, 2024
Employment, Feb 2, 2024
Sources: pubmed.ncbi.nlm.nih.gov
Mentioned in
Papers
Journal of clinical nursing, Nov 14, 2026
Clinical chemistry, Nov 13, 2026
Food patterns predicted disease risk beyond diet quality scores
medRxiv, Nov 12, 2026
Disentangling the paradox of inbreeding and telomere dynamics
Philosophical transactions of the Royal Society of London. Series B, Biological sciences, Nov 12, 2026
Kidney scores from body chemistry added to risk prediction
medRxiv, Nov 11, 2026
Mildly low platelets alone linked to modest blood disease risk
BMJ medicine, Nov 11, 2026
Hormonal Contraception Use and Changes in Body Mass Index: A Cohort Study
BJOG : an international journal of obstetrics and gynaecology, Nov 11, 2026
Artery disease exceeded pancreas inflammation at most blood fat levels
Atherosclerosis, Nov 10, 2026
Monitoring detected blood cancers with less marrow scarring
Blood advances, Nov 10, 2026
Nature communications, Nov 10, 2026
Mutant KRAS vaccination for pancreatic cancer interception: the G12D immunogenicity paradox
Signal transduction and targeted therapy, Nov 10, 2026
Peptide improved movement in mouse models of brain disease
Acta neuropathologica communications, Nov 9, 2026
AHA Scientific Sessions 2026 abstract, Nov 7, 2026
AHA Scientific Sessions 2026 abstract, Nov 7, 2026
AHA Scientific Sessions 2026 abstract, Nov 7, 2026
AHA Scientific Sessions 2026 abstract, Nov 7, 2026
A blood particle’s heart disease link is similar across ancestries
AHA Scientific Sessions 2026 abstract, Nov 7, 2026
Cardiovascular research, Nov 7, 2026
Pelacarsen did not lower major cardiovascular event risk
The New England journal of medicine, Nov 7, 2026
medRxiv, Nov 6, 2026